In this approach, researchers can simply transfect their preferred host cell—in most cases, human embryonic kidney (HEK) 293 cells—with all three plasmids in a stepwise procedure (see Figure 1).

The management of breast cancer involves various therapeutic approaches. However, many current anticancer treatments indiscriminately damage both cancerous and healthy cells. In cancer treatment, ...

OR3 exhibited potent cytotoxicity against MDA-MB-231 cells, with no observed effects on HEK-293 cells. Caspase-9 activation was detected in OR3-treated MDA-MB-231 cells. Flow cytometry showed a ...